Filing Details

Accession Number:
0001104659-18-071881
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-07 17:50:40
Reporting Period:
2018-12-06
Accepted Time:
2018-12-07 17:50:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720893 Bioxcel Therapeutics Inc. BTAI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1256126 Peter Mueller C/O Bioxcel Therapeutics, Inc.
555 Long Wharf Drive
New Haven CT 06511
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-06 1,295 $5.00 150,820 No 4 P Direct
Common Stock Acquisiton 2018-12-06 100 $5.01 150,920 No 4 P Direct
Common Stock Acquisiton 2018-12-07 495 $5.00 151,415 No 4 P Direct
Common Stock Acquisiton 2018-12-07 6,905 $5.01 158,320 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct